BACKGROUND: In France, epidemiologic data in children in ambulatory settings are scarce. We aimed to measure the burden of influenza in young children. METHODS: Febrile children younger than 36 months were consecutively recruited in a pediatric emergency department during the 2002 epidemic peak. Virology analysis and follow-up were systematic. RESULTS: During calendar weeks 3 to 6, 2002, 575 children were recruited; 49% were positive: A/H3N2 in 44% and B in 5%. Prevalence rate was 57% in 12- to 35-month-old children and 39% in infants younger than 12 months. The main clinical pictures were nonrespiratory in one third of them. One of 8 patients had a complication. One of 10 patients was hospitalized, and the estimated specific hospitalization rate for the study period was 237 of 100,000 in the general population among infants younger than 12 months. Forty-two percent of children (n = 110) were prescribed antibiotics and at least 34% of them were inappropriate (n = 89). Median length of disease was 8 days, and 25% of the children had not fully recovered by day 11. Only one child had been previously vaccinated of 65 with chronic conditions. Both epidemic strains were covered by the vaccine. CONCLUSIONS: Health outcomes showed that influenza disease burden in young French children is similar to that observed in North America. An active vaccination strategy would have strongly reduced the burden of influenza and lowered antibiotic use. Continuous efforts are needed to reach requirements of our influenza vaccination policy.
BACKGROUND: In France, epidemiologic data in children in ambulatory settings are scarce. We aimed to measure the burden of influenza in young children. METHODS: Febrile children younger than 36 months were consecutively recruited in a pediatric emergency department during the 2002 epidemic peak. Virology analysis and follow-up were systematic. RESULTS: During calendar weeks 3 to 6, 2002, 575 children were recruited; 49% were positive: A/H3N2 in 44% and B in 5%. Prevalence rate was 57% in 12- to 35-month-old children and 39% in infants younger than 12 months. The main clinical pictures were nonrespiratory in one third of them. One of 8 patients had a complication. One of 10 patients was hospitalized, and the estimated specific hospitalization rate for the study period was 237 of 100,000 in the general population among infants younger than 12 months. Forty-two percent of children (n = 110) were prescribed antibiotics and at least 34% of them were inappropriate (n = 89). Median length of disease was 8 days, and 25% of the children had not fully recovered by day 11. Only one child had been previously vaccinated of 65 with chronic conditions. Both epidemic strains were covered by the vaccine. CONCLUSIONS: Health outcomes showed that influenza disease burden in young French children is similar to that observed in North America. An active vaccination strategy would have strongly reduced the burden of influenza and lowered antibiotic use. Continuous efforts are needed to reach requirements of our influenza vaccination policy.
Authors: W Paul Glezen; Jordana K Schmier; Carrie M Kuehn; Kellie J Ryan; John Oxford Journal: Am J Public Health Date: 2013-01-17 Impact factor: 9.308
Authors: Mark G Thompson; Min Z Levine; Silvia Bino; Danielle R Hunt; Tareq M Al-Sanouri; Eric A F Simões; Rachael M Porter; Holly M Biggs; Lionel Gresh; Artan Simaku; Illham Abu Khader; Veronica L Tallo; Jennifer K Meece; Meredith McMorrow; Edelwisa S Mercado; Sneha Joshi; Nicholas P DeGroote; Iris Hatibi; Felix Sanchez; Marilla G Lucero; Samir Faouri; Stacie N Jefferson; Numila Maliqari; Angel Balmaseda; Diozele Sanvictores; Crystal Holiday; Cristina Sciuto; Zachary Owens; Eduardo Azziz-Baumgartner; Aubree Gordon Journal: Lancet Child Adolesc Health Date: 2019-09-03
Authors: Jesús San Román Montero; Ruth Gil-Prieto; Rubén Jiménez Martín; Raúl Ortiz de Lejarazu; Carmen Gallardo-Pino; Angel Gil de Miguel Journal: Hum Vaccin Immunother Date: 2020-12-22 Impact factor: 3.452
Authors: Evgeniya N Antonova; Catherine E Rycroft; Christopher S Ambrose; Terho Heikkinen; Nicola Principi Journal: BMC Public Health Date: 2012-11-12 Impact factor: 3.295
Authors: Jacqueline K Lim; Tae Hee Kim; Paul E Kilgore; Allison E Aiello; Byung Min Choi; Kwang Chul Lee; Kee Hwan Yoo; Young-Hwan Song; Yun-Kyung Kim Journal: J Korean Med Sci Date: 2014-04-01 Impact factor: 2.153
Authors: Mark G Thompson; Danielle R Hunt; Ali K Arbaji; Artan Simaku; Veronica L Tallo; Holly M Biggs; Carolyn Kulb; Aubree Gordon; Ilham Abu Khader; Silvia Bino; Marilla G Lucero; Eduardo Azziz-Baumgartner; Pat Shifflett; Felix Sanchez; Basima I Marar; Ilirjana Bakalli; Eric A F Simões; Min Z Levine; Jennifer K Meece; Angel Balmaseda; Tareq M Al-Sanouri; Majlinda Dhimolea; Joanne N de Jesus; Natalie J Thornburg; Susan I Gerber; Lionel Gresh Journal: BMC Infect Dis Date: 2017-03-22 Impact factor: 3.090
Authors: Eva Fuglsang; Angela Pizzolla; Lukasz Krych; Dennis S Nielsen; Andrew G Brooks; Hanne Frøkiær; Patrick C Reading Journal: Front Cell Infect Microbiol Date: 2018-09-12 Impact factor: 5.293